{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:33:05Z","timestamp":1787869985633,"version":"build-2784847793"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Dysregulated and excessive inflammatory reactions can lead to tissue damage, which is the underlying cause of most human diseases. Menisoxoisoaporphine A (MA), a novel oxoisoaporphine alkaloid, was obtained from Menispermi Rhizoma, a traditional Chinese medicinal herb used in the treatment of inflammatory conditions in clinical practice. This suggests that MA has very promising potential for the development of anti-inflammatory therapeutics. Hence, this study aims to investigate the anti-inflammatory effects and underlying mechanisms of MA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>The anti-inflammatory effects of MA were evaluated in lipopolysaccharide (LPS)-induced mouse macrophage RAW264.7 cells. Its underlying mechanisms were explored through RNA sequencing and Western blotting. The binding modes and interactions sites between MA and phosphodiesterase 4B (PDE4B) were predicted using molecular docking and validated by molecular dynamics simulation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>MA treatment significantly reduced LPS-induced morphological changes, inflammatory cytokine relesae, and proinflammatory genes expression in RAW264.7 cells compared to the LPS-induced controls. Transcriptome sequencing analysis suggested that PDE4B might be a key target for MA to exert its therapeutic effect. Mechanismly, MA directly acted on Tyr405 site of PDE4B, thus leading to a sustained elevation of the cyclic adenosine monophosphate (cAMP) levels, which subsequently inactivated NF-\u03baB signaling pathway by phosphorylating protein kinase A (PKA). MA inhibited the NF-\u03baB-mediated inflammatory response depending on PDE4B.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>MA, a natural and novel compound, exerted anti-inflammatory effects in LPS-induced RAW264.7 macrophage cells. It demonstrated a strong binding ability to the Tyr405 sites of PDE4B, thereby inhibiting NF-\u03baB signaling pathway by regulating the cAMP-PKA axis. Elucidating the interaction between MA and PDE4B holds significant potential for the advancement of innovative therapeutic strategies aimed at inflammatory diseases. By strategically modulating this interaction, it may be feasible to achieve more precise regulation of inflammatory responses, thereby offering promising therapeutic benefits for conditions such as rheumatoid arthritis, asthma, and inflammatory bowel disease.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2024.1505116","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T04:22:53Z","timestamp":1733199773000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Menisoxoisoaporphine A, a novel oxoisoaporphine alkaloid from Menispermi Rhizoma, inhibits inflammation by targeting PDE4B"],"prefix":"10.3389","volume":"15","author":[{"given":"Xin","family":"Qiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"key":"B1","volume-title":"Dictionary of traditional Chinese medicine","year":"1977"},{"key":"B2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1210\/er.2013-1053","article-title":"Clinical and molecular genetics of the phosphodiesterases (PDEs)","volume":"35","author":"Azevedo","year":"2014","journal-title":"Endocr. Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.3390\/ijms23031582","article-title":"Eupatilin suppresses OVA-induced asthma by inhibiting NF-\u03baB and MAPK and activating Nrf2 signaling pathways in mice","volume":"23","author":"Bai","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1164\/rccm.201301-0021PP","article-title":"Phosphodiesterase-4 inhibitor therapy for lung diseases","volume":"188","author":"Begh\u00e8","year":"2013","journal-title":"Am. J. Respir. Crit. Care. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.actbio.2015.10.031","article-title":"Resveratrol prevents alveolar bone loss in an experimental rat model of periodontitis","volume":"29","author":"Bhattarai","year":"2016","journal-title":"Acta. Biomater."},{"key":"B6","volume-title":"Pharmacopoeia of the people\u2019s Republic of China","year":"2020"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1136\/ard.2010.134825","article-title":"Phosphodiesterase 4 (PDE4) regulation of proinflammatory cytokine and chemokine release from rheumatoid synovial membrane","volume":"70","author":"Crilly","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.cell.2010.02.043","article-title":"Anti-inflammatory agents: present and future","volume":"140","author":"Dinarello","year":"2010","journal-title":"Cell"},{"key":"B9","first-page":"45","article-title":"The anti-inflammatory effects of crude total alkaloids, polyphenolic hydroxy alkaloids, and non-phenolic total alkaloids from Rhizoma Menispermi","volume":"12","author":"Du","year":"1987","journal-title":"Chin. J. Chin. Mater. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"B11","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1067\/mai.2001.119555","article-title":"Cyclic nucleotide phosphodiesterases","volume":"108","author":"Essayan","year":"2001","journal-title":"J. Allergy. Clin. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"114170","DOI":"10.1016\/j.phytochem.2024.114170","article-title":"Rare ox-oisoaporphine alkaloids from Menispermum dauricum with potential anti-inflammatory activity","volume":"225","author":"Guo","year":"2024","journal-title":"Phytochem"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.apsb.2022.07.009","article-title":"Self-therapeutic metal-based nanoparticles for treating inflammatory diseases","volume":"13","author":"Han","year":"2023","journal-title":"Acta. Pharm. Sin. B"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.1021\/acsomega.9b04233","article-title":"Fast, accurate, and reliable protocols for routine calculations of protein-ligand binding affinities in drug design projects using AMBER GPU-TI with ff14SB\/GAFF","volume":"5","author":"He","year":"","journal-title":"Acs. Omega."},{"key":"B16","doi-asserted-by":"publisher","first-page":"105134","DOI":"10.1016\/j.phrs.2020.105134","article-title":"The immunomodulatory role of PDEs inhibitors in immune cells: therapeutic implication in rheumatoid arthritis","volume":"161","author":"He","year":"","journal-title":"Pharmacol. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.bbi.2017.04.015","article-title":"The isozyme selective phosphodiesterase-4 inhibitor, ABI-4, attenuates the effects of lipopolysaccharide in human cells and rodent models of peripheral and CNS inflammation","volume":"64","author":"Hedde","year":"2017","journal-title":"Brain. Behav. Immun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","article-title":"Neutrophils in chronic inflammatory diseases","volume":"19","author":"Herrero-Cervera","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.cell.2019.10.027","article-title":"Mucosal profiling of pediatric-onset colitis and IBD reveals common pathogenics and therapeutic pathways","volume":"179","author":"Huang","year":"2019","journal-title":"Cell"},{"key":"B20","first-page":"575","article-title":"Pharmacological effects of dauricine","volume":"19","author":"Huang","year":"2007","journal-title":"Med. J. Chin. People\u2019s Health."},{"key":"B21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"B22","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1080\/19476337.2023.2245009","article-title":"Curcumin: recent updates on gastrointestinal cancers","volume":"21","author":"Imran","year":"2023","journal-title":"CyTA. J. Food."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.jaci.2010.08.014","article-title":"Phosphodiesterase 4B is essential for T(H)2-cell function and development of airway hyperresponsiveness in allergic asthma","volume":"126","author":"Jin","year":"2010","journal-title":"J. Allergy. Clin. Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1471-2105-13-173","article-title":"Defining and searching for structural motifs using DeepView\/Swiss-PdbViewer","volume":"13","author":"Johansson","year":"2012","journal-title":"Bmc. Bioinforma."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1111\/bph.14667","article-title":"Inhibition of phosphodiesterase-4 attenuates murine ulcerative colitis through interference with mucosal immunity","volume":"176","author":"Li","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.apsb.2021.04.007","article-title":"Targeting PDE4 as a promising therapeutic strategy in chronic ulcerative colitis through modulating mucosal homeostasis","volume":"12","author":"Li","year":"2022","journal-title":"Acta. Pharm. Sin. B"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3389\/fphar.2018.01048","article-title":"Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases","volume":"9","author":"Li","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"6588","DOI":"10.3390\/molecules26216588","article-title":"The involvement of PDE4 in the protective effects of melatonin on cigarette-smoke-induced chronic obstructive pulmonary disease","volume":"26","author":"Lim","year":"2021","journal-title":"Molecules"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.3390\/molecules27103267","article-title":"N-Butyrylated Hyaluronic acid achieves anti-Inflammatory effects in vitro and in adjuvant-induced immune activation in Rats","volume":"27","author":"Luan","year":"2022","journal-title":"Molecules"},{"key":"B31","volume-title":"GROMACS 2023.3 Source code (2023.3)","author":"Mark","year":"2023"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminform."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1002\/glia.22986","article-title":"PDE4B as a microglia target to reduce neuroinflammation","volume":"64","author":"Pearse","year":"2016","journal-title":"Glia"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1056\/NEJMoa2201737","article-title":"Trial of a preferential phosphodiesterase 4B inhibitor for idiopathic pulmonary fibrosis","volume":"386","author":"Richeldi","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.17576\/jsm-2021-5010-07","article-title":"Essential oil and leaves from Lantana camara significantly ameliorate different cancer cell lines by suppressing the NF-\u03baB pathway","volume":"50","author":"Sajid","year":"2021","journal-title":"Sains. Malays."},{"key":"B38","doi-asserted-by":"publisher","first-page":"102599","DOI":"10.1016\/j.bcab.2022.102599","article-title":"Downregulation of NF-\u03baB activation pathways using essential oil derived from Citrus pseudolimon: anticancer and anti-inflammatory potential","volume":"47","author":"Sajid","year":"2023","journal-title":"Agr. Biotech."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.bcp.2012.01.001","article-title":"Apremilast mechanism of action and application to psoriasis and psoriatic arthritis","volume":"83","author":"Schafer","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2022.12.020","article-title":"Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis","volume":"109","author":"Schepers","year":"2023","journal-title":"Brain. Behav. Immun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.16370\/j.cnki.13-1214\/r.2015.02.022","article-title":"Research progress on the dosage from the extract of Menispermum dauricum","volume":"30","author":"Su","year":"2015","journal-title":"J. Hebei. Trad. Chin. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3969\/j.issn.1672-8629.2009.09.010","article-title":"Research development on toxicity of rhizoma Menispermi","volume":"6","author":"Sun","year":"2009","journal-title":"Chin. J. Pharmacovigil."},{"key":"B43","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with gromacs","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theory. Comput."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/ct0502256","article-title":"The origin of layer structure artifacts in simulations of liquid water","volume":"2","author":"Van Der Spoel","year":"2006","journal-title":"J. Chem. Theory. Comput."},{"key":"B46","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jaut.2018.08.008","article-title":"Altered expression of microRNA-23a in psoriatic arthritis modulates synovial fibroblast pro-inflammatory mechanisms via phosphodiesterase 4B","volume":"96","author":"Wade","year":"2019","journal-title":"J. Autoimmun."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.2967\/jnumed.122.263838","article-title":"First-in-Human evaluation of 18F-PF-06445974, a PET radioligand that preferentially labels phosphodiesterase-4B","volume":"63","author":"Wakabayashi","year":"2022","journal-title":"J. Nucl. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1161\/CIRCRESAHA.122.321365","article-title":"Targeting PDE4B (Phosphodiesterase-4 Subtype B) for cardioprotection in acute myocardial infarction via neutrophils and microcirculation","volume":"131","author":"Wan","year":"2022","journal-title":"Circ. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.freeradbiomed.2019.11.026","article-title":"Trans-4,4'-dihydroxystilbene ameliorates cigarette smoke-induced progression of chronic obstructive pulmonary disease via inhibiting oxidative stress and inflammatory response","volume":"152","author":"Wang","year":"2020","journal-title":"Free. Radic. Biol. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"35","DOI":"10.13313\/j.issn.1673-4890.2007.09.011","article-title":"Research development on chemical constituents and pharmacological activities of Menispermum dauricum DC","volume":"9","author":"Wu","year":"2007","journal-title":"Mod. Chin. Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1007\/s10787-023-01369-9","article-title":"Recent advances in anti-inflammatory active components and action mechanisms of natural medicines","volume":"31","author":"Wu","year":"2023","journal-title":"Inflammopharmacology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"7260","DOI":"10.1038\/s41467-022-34998-9","article-title":"GPSM1 impairs metabolic homeostasis by controlling a pro-inflammatory pathway in macrophages","volume":"13","author":"Yan","year":"2022","journal-title":"Nat. Commun."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.gendis.2022.05.039","article-title":"Protective effects of IRG1\/itaconate on acute colitis through the inhibition of gasdermins-mediated pyroptosis and inflammation response","volume":"10","author":"Yang","year":"2022","journal-title":"Genes. Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"358","DOI":"10.13863\/j.issn1001-4454.2023.02.016","article-title":"Chemical constituents from the rhizomes of Menispermum dauricum","volume":"46","author":"Yao","year":"2023","journal-title":"J. Chin. Med. Mater."},{"key":"B56","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"key":"B57","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41573-020-0082-8","article-title":"Kinase inhibition in autoimmunity and inflammation","volume":"20","author":"Zarrin","year":"2021","journal-title":"Nat. Rev. Drug. Discov."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.3390\/molecules28062701","article-title":"Research progress on chemical constituents and pharmacological activities of Menispermi rhizoma","volume":"28","author":"Zhai","year":"2023","journal-title":"Molecules"},{"key":"B59","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/biom8030080","article-title":"Research progress on the relationship between atherosclerosis and inflammation","volume":"8","author":"Zhu","year":"2018","journal-title":"Biomolecules"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.apsb.2020.12.008","article-title":"Celastrol targets adenylyl cyclase-associated protein 1 to reduce macrophages-mediated inflammation and ameliorates high fat diet-induced metabolic syndrome in mice","volume":"11","author":"Zhu","year":"2021","journal-title":"Acta. Pharm. Sin. B"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1505116\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T04:23:03Z","timestamp":1733199783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1505116\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":58,"alternative-id":["10.3389\/fphar.2024.1505116"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1505116","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"article-number":"1505116"}}